Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal.
Aryatara ShilpakarMeharaj AnsariKul Raj RaiGanesh RaiShiba Kumar RaiPublished in: Tropical medicine and health (2021)
Multidrug resistance was very high; however, ESBL production was low. Polymyxin B and carbapenems are the choice of drugs against ESBL producers but should be used only as the last line drugs.